Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-022833
Filing Date
2017-03-24
Accepted
2017-03-24 18:00:31
Documents
1
Period of Report
2017-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10175
  Complete submission text file 0001209191-17-022833.txt   11801
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 (441) 824-8101
Myovant Sciences Ltd. (Issuer) CIK: 0001679082 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address THURGAUERSTRASSE 130 GLATTPARK-OPFIKON ZURICH V8 8152
Business Address THURGAUERSTRASSE 130 GLATTPARK-OPFIKON ZURICH V8 8152 41-44-555-10-00
Takeda Pharmaceuticals International AG (Reporting) CIK: 0001688140 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 17713751